2016年-数据局_WHO：糖尿病全球报告_EN_88页_8mb

报告摘要

Global Report on Diabetes Summary

Core Content

This WHO Global Report on Diabetes provides a comprehensive overview of the global burden, prevention, management, and economic impact of diabetes, highlighting the urgent need for coordinated action to address the growing epidemic.

Main Points

1. Global Burden of Diabetes

Prevalence: In 2014, an estimated 422 million adults had diabetes, compared to 108 million in 1980. The age-standardized prevalence nearly doubled from 4.7% to 8.5%.
Trends: The rise in diabetes prevalence has been faster in low- and middle-income countries than in high-income countries.
Mortality: In 2012, 1.5 million deaths were attributed to diabetes, and 2.2 million more due to high blood glucose levels. 43% of these deaths occurred before age 70.
Complications: Diabetes leads to heart attacks, stroke, kidney failure, amputation, vision loss, and nerve damage. It also increases the risk of fetal death and complications during pregnancy.

2. Prevention of Diabetes

Type 1 Diabetes: Currently not preventable.
Type 2 Diabetes: Prevention is possible through population-based policies and individual lifestyle changes such as regular exercise, healthy eating, avoiding smoking, and controlling blood pressure and lipids.
Life-course approach: Early intervention in childhood and pregnancy is critical to reducing the risk of obesity and type 2 diabetes later in life.
Multisectoral action: Governments must integrate health considerations into trade, agriculture, finance, transport, education, and urban planning.

3. Management of Diabetes

Early diagnosis: Crucial for better health outcomes. Blood glucose testing should be accessible in primary health-care settings.
Cost-effective interventions: Include blood glucose control, blood pressure and lipid management, and regular screening for eye, kidney, and foot damage.
Integrated care: Combining diabetes management with cardiovascular disease and tuberculosis/HIV/AIDS can improve outcomes.
Access to essential medicines: Human insulin and oral hypoglycaemic agents are often unavailable or unaffordable in low- and middle-income countries.

4. National Capacity for Prevention and Control

Policies and guidelines: Most countries have national diabetes policies, but implementation and funding are often lacking in low- and middle-income countries.
Health system challenges: Primary health-care facilities in low-income countries frequently lack basic technologies for diabetes diagnosis and management.
Data collection: Fewer than half of countries include blood glucose measurement in national surveys, limiting the ability to monitor trends effectively.

Key Recommendations

Establish national mechanisms for integrated NCD response with specific attention to diabetes.
Build health ministry capacity to lead and coordinate diabetes control efforts.
Promote healthy lifestyles through policies that support breastfeeding, healthy diets, and physical activity.
Strengthen health systems to ensure equitable access to essential diabetes medicines and technologies.
Improve data collection and develop diabetes registries for better monitoring and response.
Address knowledge gaps by evaluating innovative programs and their impact on behavior change and health outcomes.

Economic Impact of Diabetes

Global costs: The direct annual cost of diabetes is estimated at over $827 billion.
Health-care spending: Global health-care expenditure on diabetes tripled from 2003 to 2013.
Catastrophic expenditure: People with diabetes are more likely to incur catastrophic out-of-pocket costs in low- and middle-income countries.
GDP impact: Diabetes is projected to cost $1.7 trillion in global GDP losses from 2011 to 2030, with $900 billion in high-income and $800 billion in low- and middle-income countries.

Conclusion

Diabetes is a chronic, progressive disease with significant health and economic consequences. It is a priority noncommunicable disease under the Sustainable Development Goals (SDGs) and the WHO NCD Global Action Plan. A coordinated, multisectoral approach is essential to halt the rise of diabetes, improve access to care, and enhance the quality of life for those living with the disease. The report emphasizes the need for collective action, public investment, and policy reform to address the complex challenges of diabetes globally.

Key Risk Factors

Type 1: Genetic and environmental factors contribute to the disease, though no specific environmental causes are known.
Type 2: Linked to obesity, physical inactivity, poor diet, smoking, and family history.
Gestational Diabetes (GDM): Risk factors include age, overweight, previous GDM, family history, and high glucose levels during pregnancy.

Summary of Complications

Acute complications: Include diabetic ketoacidosis (DKA) and hyperosmolar coma, which can be life-threatening.
Chronic complications: Lead to heart disease, stroke, blindness, kidney failure, and amputation.
Impact on pregnancy: Increases the risk of fetal death, congenital malformations, and maternal complications.

Conclusion and Call to Action

The WHO Global Report on Diabetes outlines the magnitude of the diabetes epidemic and the need for a unified response across governments, health systems, civil society, and individuals. It emphasizes that no single solution exists, but multicomponent interventions can significantly reduce the burden of diabetes and its complications. The report calls for implementation of recommendations, increased investment, and policy alignment with global health goals to achieve sustainable progress in diabetes control.